Company intelligence / Profile preview

Cryogen

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

CryoGen was a medical technology company that specialized in the development of cryosurgical systems for the treatment of various medical conditions through cryoablation. The company's primary focus was on women's health and cardiovascular applications, most notably developing the Her Option Cryoablation Therapy for the treatment of menorrhagia. CryoGen's technology utilized extreme cold to destroy targeted tissue, providing a minimally invasive alternative to traditional surgical procedures. The company was acquired by Boston Scientific in 2002 to strengthen its portfolio in the rapidly growing cryotherapy market.

Therapeutic areas: CardiovascularMen's HealthWomen's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Cryogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryogen.

Explore the full profile